Board Member
CurrentGenesis Therapeutics is combining artificial intelligence and biotechnology to discover novel and breakthrough treatments for patients suffering from serious and devastating conditions. We are pioneering generative and predictive artificial intelligence technologies to develop and commercialize breakthrough treatments for patients suffering from serious and devastating diseases.We are using our proprietary, state-of-the-art generative and predictive artificial intelligence platform, called GEMS (Genesis Exploration in Molecular Space), to accelerate and optimize small molecule drug discovery and enable the discovery of new first-in-class and best-in-class drugs. Similar small molecule drugs for challenging and/or undruggable targets